Tag: biomedical
-

Two Venture Funds Unveiled for Science Start-Ups
Two investment companies announced venture capital funds totaling nearly $700 million for supporting new life science and health technology businesses.
-

AI-Aided Cancer Analytics Gain $21.5M in Early Funds
A start-up enterprise using artificial intelligence algorithms to analyze tumor biopsy images is raising $21.5 million in seed and first-round venture funding.
-

Hydrogel Shown to Boost Beneficial Gut Microbes
Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health.
-

Semiconductor Tech Drug Discovery Company Underway
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds.
-

Trial Begins for Skin-Implanted Addiction Therapy
A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks.
-

State Grant Funds Virus-Immunotherapy Cancer Trial
A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers.
-

Early Trials Show Responses for Some Blood Cancers
First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers.
-

Health Blockchain Start-Up Raises $5.5M in Seed Funds
A new enterprise aggregating and securing a wide range of health care data with blockchain technology is raising $5.5 million in seed funds.
-

Trial Begins Testing Crispr Gut Microbiome Therapy
A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers.
-

Cystic Fibrosis Start-Up Raises $111M in New Funds
A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds.